Best treatments for acute myeloid leukemia
12 products may treat acute myeloid leukemia, spanning FDA drug classes such as anthracycline topoisomerase inhibitor, isocitrate dehydrogenase 2 inhibitor, hedgehog pathway inhibitor. The current highest-rated option is idarubicin hydrochloride. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 12 drugs we list for acute myeloid leukemia, none are yet flagged as generics in our price data, spanning classes such as anthracycline topoisomerase inhibitor, isocitrate dehydrogenase 2 inhibitor, hedgehog pathway inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for acute myeloid leukemia — so confirm the right choice with your prescriber.
Top-rated picks for acute myeloid leukemia: 1. Idarubicin Hydrochloride · 2. Idhifa · 3. Xospata
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | Anthracycline Topoisomerase Inhibitor | No data | — | View → | |
| 2 | 72/100 | Prescription | Tablet | Isocitrate Dehydrogenase 2 Inhibitor | No data | — | View → | |
| 3 | 72/100 | Prescription | Tablet | — | No data | — | View → | |
| 4 | 70/100 | Prescription | Capsule | — | No data | — | View → | |
| 5 | 68/100 | Prescription | Injectable | Anthracycline Topoisomerase Inhibitor | No data | — | View → | |
| 6 | 64/100 | Prescription | Tablet | Hedgehog Pathway Inhibitor | No data | — | View → | |
| 7 | 64/100 | Prescription | Solution | Anthracycline Topoisomerase Inhibitor | No data | — | View → | |
| 8 | Not yet rated | Prescription | Capsule | — | No data | — | View → | |
| 9 | Not yet rated | Prescription | Injectable | CD33-directed Immunoconjugate | No data | — | View → | |
| 10 | Not yet rated | Prescription | Capsule | — | No data | — | View → |
Narrow by drug class
Explore the class hubs: anthracycline topoisomerase inhibitor
Full ranking · 12 treatments
idarubicin hydrochloride
Boxed warningPrescriptionFDA-sourced
Idarubicin Hydrochloride is an anthracycline topoisomerase inhibitor used to treat Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Price varies
idhifa
Boxed warningPrescriptionFDA-sourced
Idhifa (Enasidenib Mesylate) is an isocitrate dehydrogenase 2 inhibitor used to treat Acute Myeloid Leukemia.
Price varies
xospata
Boxed warningPrescriptionFDA-sourced
Xospata (Gilteritinib Fumarate) is a medication used to treat Acute Myeloid Leukemia.
Price varies
rydapt
PrescriptionFDA-sourced
Rydapt (Midostaurin) is a medication used to treat Acute Myeloid Leukemia, Hematologic Neoplasms, Systemic Mastocytosis.
Price varies
daunorubicin hydrochloride
PrescriptionFDA-sourced
Daunorubicin Hydrochloride is an anthracycline topoisomerase inhibitor used to treat Acute Myeloid Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Price varies
daurismo
Boxed warningPrescriptionFDA-sourced
Daurismo (Glasdegib Maleate) is a hedgehog pathway inhibitor used to treat Acute Myeloid Leukemia.
Price varies
Frequently asked
- What treats acute myeloid leukemia?
- Our catalog lists 12 products that may treat acute myeloid leukemia, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is idarubicin hydrochloride.
- What is the best-rated treatment for acute myeloid leukemia?
- By our independent recall-safety rating — not an efficacy measure — idarubicin hydrochloride ranks highest among the products we list for acute myeloid leukemia. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat acute myeloid leukemia?
- Treatments for acute myeloid leukemia span FDA drug classes including anthracycline topoisomerase inhibitor, isocitrate dehydrogenase 2 inhibitor, hedgehog pathway inhibitor, cd33-directed immunoconjugate. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.